Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com//news-release/2024/02/29/2837904/0/en/Clene-Presents-Clinical-Results-of-CNM-Au8-30mg-Treatment-From-Visionary-MS-Trial-Long-Term-Extension-at-Annual-ACTRIMS-Forum-2024.html
https://www.biospace.com/article/fda-rejects-clene-for-accelerated-approval/
https://www.globenewswire.com//news-release/2023/12/21/2799888/0/en/Clene-Reports-Reduction-in-Biomarker-Plasma-Neurofilament-Light-NfL-Levels-and-Improved-Survival-With-CNM-Au8-Treatment-From-HEALEY-ALS-Platform-Trial-Long-Term-Open-Label-Extensio.html
https://www.globenewswire.com//news-release/2023/12/21/2799889/0/en/Clene-Provides-Update-on-ALS-Clinical-Development-Meeting-With-FDA.html
https://www.globenewswire.com//news-release/2023/12/14/2796279/0/en/Clene-Announces-Peer-Reviewed-Publication-Describing-CNM-Au8-Brain-Target-Engagement-In-Neurodegenerative-Diseases.html
https://www.globenewswire.com//news-release/2023/11/07/2775027/0/en/Clene-Reports-Third-Quarter-2023-Financial-Results-and-Operating-Highlights.html
https://www.globenewswire.com//news-release/2023/09/28/2751156/0/en/Clene-Announces-Peer-Reviewed-Publication-Describing-CNM-Au8-Catalytic-Neuroprotective-Mechanism-of-Action.html
https://www.globenewswire.com//news-release/2023/09/25/2748500/0/en/Clene-Reports-Significant-Long-Term-Survival-Improvement-From-CNM-Au8-Treatment-in-HEALEY-ALS-Platform-Trial-Compared-to-PRO-ACT-Historical-Controls.html
https://www.globenewswire.com//news-release/2023/09/25/2748968/0/en/Clene-to-Present-at-Cantor-Fitzgerald-Annual-Global-Healthcare-Conference.html
https://www.globenewswire.com/news-release/2023/08/14/2724322/0/en/Clene-Reports-Second-Quarter-2023-Financial-Results-and-Operating-Highlights.html